Helix BioPharma Corp. (HBP : TSX)
Common Stock
$1.90
CAD
-0.04 (-2.06%)
Last updated: 2026-08-27
Get HBP alerts:
HBP
Helix BioPharma Corp.
WealthAwesomePerformance
1 Day
-2.06%
1 Week
-5.00%
1 Month
+31.03%
YTD
-20.83%
Key Statistics
Market Cap
$145.12M
52W High
$5.40
52W Low
$1.10
P/E Ratio
-
50 Day MA
$1.57
200 Day MA
$1.87
Beta
-0.35
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/27/2026 | $1.95 | $1.95 | $1.90 | $1.90 | $1.90 | 218 |
| 8/26/2026 | $1.94 | $1.95 | $1.94 | $1.94 | $1.94 | 5,756 |
| 8/25/2026 | $1.98 | $2.03 | $1.76 | $1.99 | $1.99 | 8,001 |
| 8/24/2026 | $1.98 | $2.02 | $1.83 | $2.01 | $2.01 | 1,444 |
| 8/21/2026 | $2.04 | $2.05 | $1.91 | $1.97 | $1.97 | 2,535 |
| 8/20/2026 | $2.00 | $2.03 | $2.00 | $2.00 | $2.00 | 512 |
| 8/19/2026 | $2.00 | $2.02 | $2.00 | $2.00 | $2.00 | 2,239 |
| 8/18/2026 | $2.06 | $2.08 | $1.99 | $2.00 | $2.00 | 7,148 |
| 8/17/2026 | $1.94 | $2.08 | $1.86 | $2.02 | $2.02 | 6,655 |
| 8/14/2026 | $1.78 | $1.94 | $1.78 | $1.87 | $1.87 | 3,228 |
Analyst Price Targets
Based on analyst covering HBP
Wall Street analysts forecast HBP stock price to rise 31.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.50
+31.6% Upside
Current Price
C$1.90
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HBP's historical volatility
30-Day Vol
39.4%
Annualized
90-Day Vol
58.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.27
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.02 | C$1.76 – C$2.31 |
| 60 trading days | C$2.14 | C$1.77 – C$2.59 |
| 90 trading days | C$2.27 | C$1.79 – C$2.88 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Helix BioPharma Corp.
Helix BioPharma Corp. a clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada. Its product pipeline comprises L-DOS47, a clinical-stage antibody-enzyme conjugate (AEC) that neutralizes the microenvironment of solid tumors; LDOS001, which is in phase I clinical trial to treat non-small cell lung cancer; LDOS002, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer; LDOS003, which is in phase II clinical trial to treat non-small cell lung cancer; LDOS006, which is in phase Ib/II for the treatment of pancreatic cancer; and LDOS007, which is in phase Ib/II for the treatment of lung cancer. It develops V-DOS47, an antibody-DOS47 conjugate that targets the vascular endothelial growth factor 2 receptor. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company has an agreement with metaShape Pharma AG for covering LEUMUNA, within the field of adipose tissue-related and metabolic diseases. Helix BioPharma Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-3.25M
- Profit Margin
- 0.00%
- ROE (TTM)
- -49.99%
- EPS (Diluted)
- -0.04
- Book Value
- 0.19
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
🔄 Recent Splits
1-for-5
Aug 16, 2024
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About HBP
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| PDI | PDI Gold Limited | $4.10 | +336.17% |
| ELR | Eastern Platinum Limited | $0.48 | +37.14% |
| GRC | Gold Springs Resource Corp | $0.07 | +15.38% |
| CJR-B | Corus Entertainment Inc | $0.04 | +14.29% |
| EGLX | Enthusiast Gaming Holdings Inc | $0.04 | +12.50% |
| CVVY | Cavvy Energy Ltd. | $2.18 | +12.37% |
| RTG | RTG Mining Inc | $0.05 | +11.11% |
| BB | BlackBerry Ltd | $11.97 | +10.83% |
HBP.TO news timeline
15 articles covering HBP.TO, most recent first
LatestWhat's Going On With Helix BioPharma Corp. Stock Thursday?
August 2026
- What's Going On With Helix BioPharma Corp. Stock Thursday?
- Why Helix BioPharma Corp. stock is gaining today
- Why Helix BioPharma Corp. stock is rising today
- Why Helix BioPharma Corp. stock is skyrocketing today
- What's Going On With Helix BioPharma Corp. Stock Thursday?
- Why Helix BioPharma Corp. stock is rising today
- Why Helix BioPharma Corp. stock is rising today
- What's Going On With Helix BioPharma Corp. Stock Thursday?
- Why Helix BioPharma Corp. stock is sliding today